Safety profile of enantiomers versus racemic mixture: it's the same?
Conclusion The profile of ADRs could differ for some drugs marketed as racemate and enantiomer form. Further studies would be necessary to confirm these data.© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society (Source: British Journal of Clinical Pharmacology)

Citalopram is a more potent platelet function inhibitor than paroxetine in a case‐control study.
(Source: Journal of Thrombosis and Haemostasis)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div